Disease Progression of Hospitalized Elderly Patients with Omicron BA.2 Treated with Molnupiravir

DOI record: { "DOI": "10.1007/s40121-022-00716-7", "ISSN": [ "2193-8229", "2193-6382" ], "URL": "http://dx.doi.org/10.1007/s40121-022-00716-7", "alternative-id": [ "716" ], "assertion": [ { "group": { "label": "Article History", "name": "ArticleHistory" }, "label": "Received", "name": "received", "order": 1, "value": "8 August 2022" }, { "group": { "label": "Article History", "name": "ArticleHistory" }, "label": "Accepted", "name": "accepted", "order": 2, "value": "12 October 2022" }, { "group": { "label": "Article History", "name": "ArticleHistory" }, "label": "First Online", "name": "first_online", "order": 3, "value": "30 October 2022" } ], "author": [ { "affiliation": [], "family": "Liu", "given": "Yayun", "sequence": "first" }, { "affiliation": [], "family": "Ge", "given": "Lingling", "sequence": "additional" }, { "affiliation": [], "family": "Fan", "given": "Shiyong", "sequence": "additional" }, { "affiliation": [], "family": "Xu", "given": "Aijing", "sequence": "additional" }, { "affiliation": [], "family": "Wang", "given": "Xinyu", "sequence": "additional" }, { "affiliation": [], "family": "Dong", "given": "Xu", "sequence": "additional" }, { "affiliation": [], "family": "Xu", "given": "Mingxiao", "sequence": "additional" }, { "affiliation": [], "family": "Fan", "given": "Wenhan", "sequence": "additional" }, { "affiliation": [], "family": "Zhong", "given": "Wu", "sequence": "additional" }, { "affiliation": [], "family": "Liang", "given": "Xuesong", "sequence": "additional" } ], "container-title": "Infectious Diseases and Therapy", "container-title-short": "Infect Dis Ther", "content-domain": { "crossmark-restriction": false, "domain": [ "link.springer.com" ] }, "created": { "date-parts": [ [ 2022, 10, 30 ] ], "date-time": "2022-10-30T17:02:36Z", "timestamp": 1667149356000 }, "deposited": { "date-parts": [ [ 2022, 10, 30 ] ], "date-time": "2022-10-30T17:09:08Z", "timestamp": 1667149748000 }, "funder": [ { "award": [ "COVID-ZD-006", "COVID-ZD-011" ], "name": "Key research project of COVID-19 by Changhai hospital of Naval Medical University" }, { "award": [ "2021YFC2300704" ], "name": "the National Key Research and Development Project" } ], "indexed": { "date-parts": [ [ 2022, 10, 31 ] ], "date-time": "2022-10-31T04:44:37Z", "timestamp": 1667191477310 }, "is-referenced-by-count": 0, "issued": { "date-parts": [ [ 2022, 10, 30 ] ] }, "language": "en", "license": [ { "URL": "https://creativecommons.org/licenses/by-nc/4.0", "content-version": "tdm", "delay-in-days": 0, "start": { "date-parts": [ [ 2022, 10, 30 ] ], "date-time": "2022-10-30T00:00:00Z", "timestamp": 1667088000000 } }, { "URL": "https://creativecommons.org/licenses/by-nc/4.0", "content-version": "vor", "delay-in-days": 0, "start": { "date-parts": [ [ 2022, 10, 30 ] ], "date-time": "2022-10-30T00:00:00Z", "timestamp": 1667088000000 } } ], "link": [ { "URL": "https://link.springer.com/content/pdf/10.1007/s40121-022-00716-7.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining" }, { "URL": "https://link.springer.com/article/10.1007/s40121-022-00716-7/fulltext.html", "content-type": "text/html", "content-version": "vor", "intended-application": "text-mining" }, { "URL": "https://link.springer.com/content/pdf/10.1007/s40121-022-00716-7.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "similarity-checking" } ], "member": "297", "original-title": [], "prefix": "10.1007", "published": { "date-parts": [ [ 2022, 10, 30 ] ] }, "published-online": { "date-parts": [ [ 2022, 10, 30 ] ] }, "publisher": "Springer Science and Business Media LLC", "reference": [ { "DOI": "10.1016/j.amsu.2022.103737", "author": "F Islam", "doi-asserted-by": "publisher", "first-page": "103737", "journal-title": "Ann Med Surg (Lond).", "key": "716_CR1", "unstructured": "Islam F, Dhawan M, Nafady MH, et al. Understanding the omicron variant (B.1.1.529) of SARS-CoV-2: mutational impacts, concerns, and the possible solutions. Ann Med Surg (Lond). 2022;78:103737. https://doi.org/10.1016/j.amsu.2022.103737.", "volume": "78", "year": "2022" }, { "DOI": "10.15585/mmwr.mm7115e1", "author": "DJ Smith", "doi-asserted-by": "publisher", "first-page": "545", "issue": "15", "journal-title": "MMWR Morb Mortal Wkly Rep", "key": "716_CR2", "unstructured": "Smith DJ, Hakim AJ, Leung GM, et al. COVID-19 mortality and vaccine coverage—Hong Kong Special Administrative Region China, January 6, 2022–March 21, 2022. MMWR Morb Mortal Wkly Rep. 2022;71(15):545–8. https://doi.org/10.15585/mmwr.mm7115e1.", "volume": "71", "year": "2022" }, { "DOI": "10.1056/NEJMoa2116044", "author": "A Jayk Bernal", "doi-asserted-by": "publisher", "first-page": "509", "issue": "6", "journal-title": "N Engl J Med", "key": "716_CR3", "unstructured": "Jayk Bernal A, Gomes da Silva MM, Musungaie DB, et al. Molnupiravir for oral treatment of Covid-19 in nonhospitalized patients. N Engl J Med. 2022;386(6):509–20. https://doi.org/10.1056/NEJMoa2116044.", "volume": "386", "year": "2022" }, { "DOI": "10.1016/j.cell.2021.12.046", "author": "W Dejnirattisai", "doi-asserted-by": "publisher", "first-page": "467", "issue": "3", "journal-title": "Cell", "key": "716_CR4", "unstructured": "Dejnirattisai W, Huo J, Zhou D, et al. SARS-CoV-2 Omicron-B.1.1.529 leads to widespread escape from neutralizing antibody responses. Cell. 2022;185(3):467-84e15. https://doi.org/10.1016/j.cell.2021.12.046.", "volume": "185", "year": "2022" }, { "DOI": "10.3389/fimmu.2022.877101", "author": "Y Guo", "doi-asserted-by": "publisher", "first-page": "877101", "journal-title": "Front Immunol", "key": "716_CR5", "unstructured": "Guo Y, Han J, Zhang Y, et al. SARS-CoV-2 omicron variant: epidemiological features, biological characteristics, and clinical significance. Front Immunol. 2022;13:877101. https://doi.org/10.3389/fimmu.2022.877101.", "volume": "13", "year": "2022" }, { "DOI": "10.1097/MD.0000000000029165", "author": "M Mohsin", "doi-asserted-by": "publisher", "issue": "19", "journal-title": "Medicine (Baltimore)", "key": "716_CR6", "unstructured": "Mohsin M, Mahmud S. Omicron SARS-CoV-2 variant of concern: a review on its transmissibility, immune evasion, reinfection, and severity. Medicine (Baltimore). 2022;101(19): e29165. https://doi.org/10.1097/MD.0000000000029165.", "volume": "101", "year": "2022" }, { "DOI": "10.1126/scitranslmed.abm7621", "author": "L Cao", "doi-asserted-by": "publisher", "journal-title": "Sci Transl Med.", "key": "716_CR7", "unstructured": "Cao L, Li Y, Yang S, et al. The adenosine analog prodrug ATV006 is orally bioavailable and has preclinical efficacy against parental SARS-CoV-2 and variants. Sci Transl Med. 2022. https://doi.org/10.1126/scitranslmed.abm7621.", "year": "2022" }, { "DOI": "10.1101/2022.05.19.22275291", "author": "CKH Wong", "doi-asserted-by": "publisher", "journal-title": "medRxiv.", "key": "716_CR8", "unstructured": "Wong CKH, Au ICH, Lau KTK, Lau EHY, Cowling BJ, Leung GM. Real-world effectiveness of molnupiravir and nirmatrelvir/ritonavir among COVID-19 inpatients during Hong Kong’s Omicron BA.2 wave: an observational study. medRxiv. 2022. https://doi.org/10.1101/2022.05.19.22275291.", "year": "2022" }, { "DOI": "10.1016/j.antiviral.2022.105252", "author": "L Vangeel", "doi-asserted-by": "publisher", "journal-title": "Antiviral Res", "key": "716_CR9", "unstructured": "Vangeel L, Chiu W, De Jonghe S, et al. Remdesivir, molnupiravir and nirmatrelvir remain active against SARS-CoV-2 omicron and other variants of concern. Antiviral Res. 2022;198: 105252. https://doi.org/10.1016/j.antiviral.2022.105252.", "volume": "198", "year": "2022" }, { "DOI": "10.1056/NEJMc2119407", "author": "E Takashita", "doi-asserted-by": "publisher", "first-page": "995", "issue": "10", "journal-title": "N Engl J Med", "key": "716_CR10", "unstructured": "Takashita E, Kinoshita N, Yamayoshi S, et al. Efficacy of antibodies and antiviral drugs against Covid-19 Omicron variant. N Engl J Med. 2022;386(10):995–8.", "volume": "386", "year": "2022" }, { "DOI": "10.1101/2022.05.26.22275631", "author": "CKH Wong", "doi-asserted-by": "publisher", "journal-title": "medRxiv", "key": "716_CR11", "unstructured": "Wong CKH, Au ICH, Lau KTK, Lau EHY, Cowling BJ, Leung GM. Real-world effectiveness of molnupiravir and nirmatrelvir/ritonavir against mortality, hospitalization, and in-hospital outcomes among community-dwelling, ambulatory COVID-19 patients during the BA.2.2 wave in Hong Kong: an observational study. medRxiv. 2022. https://doi.org/10.1101/2022.05.26.22275631.", "year": "2022" }, { "DOI": "10.1056/NEJMoa2118542", "author": "J Hammond", "doi-asserted-by": "publisher", "first-page": "1397", "issue": "15", "journal-title": "N Engl J Med", "key": "716_CR12", "unstructured": "Hammond J, Leister-Tebbe H, Gardner A, et al. Oral nirmatrelvir for high-risk, nonhospitalized adults with Covid-19. N Engl J Med. 2022;386(15):1397–408. https://doi.org/10.1056/NEJMoa2118542.", "volume": "386", "year": "2022" } ], "reference-count": 12, "references-count": 12, "relation": {}, "resource": { "primary": { "URL": "https://link.springer.com/10.1007/s40121-022-00716-7" } }, "score": 1, "short-title": [], "source": "Crossref", "subject": [ "Infectious Diseases", "Microbiology (medical)" ], "subtitle": [], "title": "Disease Progression of Hospitalized Elderly Patients with Omicron BA.2 Treated with Molnupiravir", "type": "journal-article", "update-policy": "http://dx.doi.org/10.1007/springer_crossmark_policy" }